Therapy for primary pulmonary hypertension.
McCormack
Dave
D
London Health Sciences Centre, London, Ontario, Canada. david.mccormack@lhsc.on.ca
D000284:Administration, Oral; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000191:economics; D000077300:Bosentan; D011464:Epoprostenol / Q000008:administration & dosage* / Q000191:economics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007262:Infusions, Intravenous; D018579:Patient Selection; D011306:Prescription Fees; D013449:Sulfonamides / Q000008:administration & dosage* / Q000191:economics; D014666:Vasomotor System / Q000187:drug effects
D000959:Antihypertensive Agents; D013449:Sulfonamides; D011464:Epoprostenol; D000077300:Bosentan